We have studied the analgesic efficacy of a single i.v. dose of tenoxicam 20 mg, given 10 min before induction of anaesthesia in 25 patients undergoing elective Caesarean section. Another group of 25 similar patients served as controls. Nalbuphine consumption in the first 24 h after operation was reduced by 50% when tenoxicam was given. The median time to first request for analgesia was increased from 25 to 110 min in the tenoxicam group. Subjective experiences of pain and sedation were significantly greater in the control group up to 24 h after operation. The haemodynamic variability after intubation was of shorter duration in the tenoxicam group. There was no significant difference in incidence and severity of postoperative nausea and vomiting between the two groups. The surgeon's assessment of uterine relaxation and bleeding, using a visual analogue score, and infant well-being, as judged by Apgar score and cord blood-gas analysis, showed no significant difference between the two groups. There was no evidence of premature closure of the ductus arteriosus or pulmonary hypertension. We conclude that a single i.v. dose of tenoxicam is a useful pretreatment to minimize the haemodynamic variability of light general anaesthesia at induction-delivery and in reducing 24 h postoperative opioid consumption. (Br. J. Anaesth. 1995; 74: 643-646) 
Patients undergoing Caesarean section mobilize early and might benefit from the addition of supplementary analgesia by non-steroidal anti-inflammatory drugs (NSAID) which may reduce opioid requirements and the incidence of related side effects [1] .
The analgesic effects of NSAID have been investigated in patients after Caesarean section [2] . It is preferable to give NSAID before synthesis of prostaglandins is initiated by tissue trauma [3] . The aim of this study was to assess the value of a single dose of i.v. tenoxicam given before elective Caesarean section performed under general anaesthesia.
Patients and methods
We studied 50 ASA I women undergoing elective Caesarean section. The study was approved by the hospital Ethics Committee and all participants gave informed consent to this double-blind study. Mothers with a history of asthma, drug allergy or sensitivity to opioids or anti-inflammatory drugs were excluded.
No premedication was prescribed. The patients were transported to the operating theatre in the lateral position, and 15° left lateral tilt was maintained on the operating table. An 18-gauge cannula was inserted into a forearm vein, and ECG and indirect arterial pressure monitor (Dinamap) attached.
Patients were allocated randomly to one of two groups to receive tenoxicam 20 mg (Tilcotil) (0.3 mg kg" 1 ) (group A) or an equal volume of normal saline (group B) i.v. 10 min before induction of anaesthesia, given by an independent operator. Sodium bicarbonate 8.4 % (10 ml) was given orally before induction of anaesthesia. After 3 min of preoxygenation, general anaesthesia was induced with propofol 2 mg kg" 1 followed rapidly by suxamethonium 1 mg kg" 1 . Cricoid pressure was applied after loss of consciousness and maintained until a tracheal airway was secured in place. Anaesthesia was maintained with a mixture of 50 % nitrous oxide and 0.5% halothane in oxygen. Atracurium 0.5 mg kg" 1 was given to maintain neuromuscular block after recovery from suxamethonium. Ventilation was controlled to produce normocapnia, confirmed by measuring end-tidal carbon dioxide concentration. Systolic, mean and diastolic pressures, and heart rate were recorded every 1 min for the first 20 min. An infusion of compound sodium lactate solution 500 ml was given over the first 10 min.
After the umbilical cord was clamped, an infusion of oxytocin 20 u. in 500 ml of 5 % glucose was started, nalbuphine 0.25 mg kg" 1 was given i.v. and nitrous oxide was increased to 67 %. Halothane was discontinued at the start of skin suture and nitrous oxide was stopped 2 min later. Residual neuromuscular block was antagonized with neostigmine 2.5 mg and atropine 1.2 mg.
The surgeon graded uterine relaxation on an unmarked 10-cm visual analogue scale; 0 indicated none and 10 severe relaxation. In combination with the need for supplementary doses of oxytocin, this gave a clinical indication of the degree of uterine relaxation. The mother's haemoglobin concentration and packed cell volume (PCV) were recorded before and after (24 h) operation. All mothers were questioned during the first postoperative day about intraoperative dreaming or awareness.
All neonates were assessed by a single paediatrician who was unaware of the analgesic drug given. Apgar scores were recorded at 1 and 5 min. Umbilical venous and arterial blood-gas analyses were performed at delivery. The paediatrician examined each newborn immediately after delivery and during 8 h in hospital for any evidence of premature closure of the ductus arteriosus or pulmonary hypertension [4] . The newborns were observed with monitoring of arterial pressure, heart rate, temperature and arterial oxygen saturation (Spo,)-Nalbuphine 10-20 mg i.m. was prescribed every 4 h after operation. The ward nurses were instructed to halve or omit these 4-hourly doses if they considered that the patient was oversedated or painfree.
The anaesthetist visited the patients at 6, 12, 18 and 24 h after surgery. The patients were asked to record the severity of pain on a 10-cm analogue scale [5] , which ranged from 0 for no pain to 10 for the worst pain imaginable. The frequency and severity of nausea and vomiting were assessed as (0) no nausea, (1) mild-moderate nausea, (2) mild vomiting (once per observation period) with severe nausea, (3) moderate vomiting (twice per observation period), (4) severe vomiting (3-4 times per observation period) and, (5) persistent vomiting that needed treatment with an antiemetic agent. Four-point verbal rating scores (VRS) were used to rate sedation (awake, drowsy, rousable or deep sleep). The consumption of postoperative analgesics was recorded.
Statistical analysis was performed using Student's t test, chi-square test (with Yates' correction when necessary) and ANOVA, as appropriate. P < 0.05 was considered significant.
Results
There were no differences in characteristics between the groups (table 1). The cumulative dose of nalbuphine was significantly greater at 24 h in the control group (P < 0.01) (mean 46 (SEM 2.60) mg) than in the tenoxicam group (22 (1.82) mg). Analysis of nalbuphine used in 6-hourly epochs revealed a significantly greater use in the control group compared with the tenoxicam group ( fig. 1 ). The median time to first request for analgesia was increased from 25 to 110 min in the tenoxicam group. Linear analogue scores for pain were significantly lower in the tenoxicam group at immediate recovery, 6 and 12 h (P < 0.01) and at 18 and 24 h (P < 0.05) ( fig. 2) . VRS scores for sedation were significantly lower in the tenoxicam group at 6 h (P < 0.01) and at 12 and 24 h (P < 0.05) (table 2). At 24 h after operation, the incidence and severity of nausea and vomiting were similar in both groups (table 3) .
There were no differences in mean baseline values of systolic arterial pressure and heart rate between the two groups. These increased after intubation in both groups (P < 0.01) and returned to baseline ) and control ( ) groups. * P < 0 05, ** P < 0 001.
levels by 4-6 min in the tenoxicam group and 7-10 min in the control group. Data related to uterine relaxation and bleeding are shown in table 4. The surgeon's assessments of relaxation indicated that there was no significant difference between the two groups. Four patients in the control group required additional oxytocin compared with nine given tenoxicam, but this difference was not significant. Additional oxytocin Umbilical blood-gas analysis, and neonatal Apgar scores were satisfactory and similar between groups (table 5). There was no evidence of premature closure of the ductus arteriosus or pulmonary hypertension in the newborns of the two groups. There were no reported postoperative differences in the follow-up examination of the cardiovascular condition of the newborns in both groups, including the state of the ductus arteriosus.
Discussion
We have found that administration of a single dose of i.v. tenoxicam before Caesarean section reduced nalbuphine consumption during the first postoperative day by 50%, with superior analgesia and less sedation. These results are in agreement with previous work which demonstrated that NSAID reduced opioid requirements after lower abdominal surgery [6] [7] [8] . It has been suggested that giving NSAID before surgery begins may minimize the initiation of pain in the tissues and enhance their effectiveness as analgesics [9] . This may explain the considerable reduction in opioid consumption observed in the present study compared with previous studies. The pain scores were high in our control group compared with the finding of others who studied pain relief after Caesarean section [10, 11] , possibly because of the use of i.m. opioids on request rather than patient-controlled analgesia.
Tenoxicam is eliminated with mean half-life of 72 h, because of low hepatic extraction [12] . This may explain the reduction in pain and sedation scores over the first 24 h after operation. Meanwhile, there was no reduction in the incidence of nausea and vomiting in the patients given tenoxicam despite reduced opioid consumption. This is expected because many other factors have been shown to influence the incidence of postoperative nausea and vomiting in addition to analgesic agents [13] . The haemodynamic changes during the inductionincision interval were less variable in the tenoxicam group. Variations in arterial pressure and heart rate during Caesarean section are influenced more by the rapid circulatory changes in volume during surgery and delivery than the anaesthetic technique. However, the addition of tenoxicam as an analgesic agent may attenuate haemodynamic variables during induction.
Tenoxicam did not increase the extent of uterine relaxation or bleeding. It is difficult to assess blood loss accurately during Caesarean section but the method used here seemed to give a reliable estimation. No patient required blood transfusion and changes in haemoglobin concentration and PCV before and after operation did not indicate excessive blood loss. Previous studies have found that preoperative administration of small doses of NSAID do not increase blood loss after gynaecological surgery, laparotomy [14] or transurethral prostatectomy [15] , while full doses have been shown to increase intraoperative blood loss [16] . Power and colleagues [17] demonstrated that diclofenac prolonged bleeding time and reduced platelet aggregation within 1 h. Therefore, it may be prudent to avoid the use of NSAID during operation in the presence of other defects of haemostasis or coagulation.
There was no difference in neonatal outcome, as determined by Apgar scores, between the two groups, and blood pH and blood-gas studies did not suggest any impairment of placental perfusion or fetal circulation with tenoxicam. NSAID are known to induce premature closure of the patent ductus arteriosus (PDA) when given in large doses to mothers before delivery [18] . In this study there was no clinical evidence of premature closure of the PDA after tenoxicam 20 mg. These results agree with previous work by Zuckerman and colleagues [19] who demonstrated the efficacy of indomethacin in the inhibition of premature labour with no evidence of premature closure of the PDA. The breast milk of women treated with NSAID contains extremely small amounts of the drug, a quantity not thought likely to represent a hazard to the infants of breast feeding mothers [20, 21] . There were no problems attributed to tenoxicam in our infants, although no conclusions can be drawn about safety from such a small number.
